Magnetic nanoparticles for drug delivery

  title={Magnetic nanoparticles for drug delivery},
  author={Jon Dobson},
  journal={Drug Development Research},
  • J. Dobson
  • Published 1 January 2006
  • Materials Science
  • Drug Development Research
Targeting specific sites in vivo for the delivery of therapeutic compounds presents a major obstacle to the treatment of many diseases. One targeted delivery technique that has gained prominence in recent years is the use of magnetic nanoparticles. In these systems, therapeutic compounds are attached to biocompatible magnetic nanoparticles and magnetic fields generated outside the body are focused on specific targets in vivo. The fields capture the particle complex resulting in enhanced… 
Magnetic nanoparticles and targeted drug delivering.
This review summarizes the most commonly used functionalization methods of the MNPs preparation methods and their use in targeted drug delivery and targeted therapy.
Initial basic and clinical studies have indicated magnetic nanoparticles (NPs) as the next generation of targeted drug delivery. MNP-based targeted drug delivery and therapy provides a localized and
Application of Magnetic NanoMaterials in Tumor Targeted Therapy
The targeted drug delivery system is the combination of nanotechnology, biotechnology and magnetic targeting technology. Combined with excellent magnetic targeted property, the drug is gathered
Magnetic nanoparticles for gene and drug delivery
Advances in magnetic nanoparticle design, in vitro and animal experiments with magnetic nanoparticles-based drug and gene delivery, and clinical trials of drug targeting are reviewed.
Nanomedicine for targeted drug delivery
This review focuses on the design, synthesis and unique properties of nanoparticles used in nanomedicine as well as on clinical uses for both diagnosis and treatment of disease.
Functionalization of Magnetic Nanoparticles for Drug Delivery
  • 2018
Magnetic nanoparticles (MNPs) possess unique magnetic properties and the ability to function at the cellular and molecular level of biological interactions making them an attractive platform as
Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer
Both in vitro and in vivo studies using MT2 mouse breast cancer cell models demonstrate that the magnetic targeting of porous silica nanocapsules allows for deep tumor penetration and subsequent on-demand release of the drug cargo, significantly reducing tumor cell viability.
Magnetic targeting for site-specific drug delivery: applications and clinical potential
Background: Magnetic vehicles are very attractive for delivery of therapeutic agents as they can be targeted to specific locations in the body through the application of a magnetic field gradient.
Targeted Delivery of Protein Drugs by Nanocarriers
Recent advances in biotechnology demonstrate that peptides and proteins are the basis of a new generation of drugs. However, the transportation of protein drugs in the body is limited by their high
Hybrid Nanoparticles as Drug Carriers for Controlled Chemotherapy of Cancer.
This Personal Account highlights the recent research advances of some representative hybrid nanoparticles as drug delivery systems and discusses their design strategies and responsive mechanisms for controlled drug delivery.


Biodegradable nanoparticles for drug delivery and targeting
Throughout the world today, numerous researchers are exploring the potential use of polymeric nanoparticles as carriers for a wide range of drugs for therapeutic applications. Because of their
Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1
  • K. Widder, A. Senyei, D. Scarpelli
  • Chemistry, Medicine
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
  • 1978
Results indicate that the carrier, albumin microspheres with entrapped Fe3O4, and adriamycin HCl, can be concentrated at a predetermined site in vivo by a magnetic field.
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
Nanoparticles can be used in biomedical applications, where they facilitate laboratory diagnostics, or in medical drug targeting. They are used for in vivo applications such as contrast agent for
In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles
Magnetic drug targeting is a local drug delivery system. Electromicroscopic pictures document the ferrofluid enrichment in the intracellular space in vitro. In vivo experiments were performed in VX2
Targeted drug delivery to magnetic implants for therapeutic applications
Theoretical simulations and experimental results support the assumption that using magnetic implants in combination with externally applied magnetic field will optimize the delivery of magnetic drug to selected sites within a subject.
Physiological aspects in magnetic drug-targeting
The efficacy of magnetically-controlled drug targeting (MDT) depends on physiological parameters. To understand its mechanism of action on the tissue at the microcirculatory level, we identified the
Magnetic guidance of drug‐carrying microspheres
Physical laws underlying the intravascular magnetic guidance of a novel drug carrier are discussed. The drug carrier is a magnetically responsive drug‐bearing microsphere measuring approximately 1 μm
Preparation and Characterization of Magnetic Targeted Drug Controlled-Release Hydrogel Microspheres
Magnetic targeted drug controlled release hydrogel microspheres were prepared by a radiation technique. Ferric oxide granules (size around 50 nm) were used as the core for magnetic target. The PVP
Hydrodynamics of magnetic drug targeting.
The aim of the present work is to classify the emerging problems and propose satisfactory answers to magnetic drug targeting, and a general phenomenological theory is developed and a model case is studied, which incorporates all the physical parameters of the problem.
Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.
The present results indicated that intravenously administered magnetic ADR liposomes can be used to effectively deliver ADR to osteosarcoma implanted with a magnet, as well as to the lung, a common site of metastases for osteosARcoma.